Clot-Busting Drug May Be Safe for People with Stroke and Unruptured Aneurysms

Translate to Spanish or other 102 languages!

Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. Image for illustration purposes.

Mega Doctor News

- Advertisement -

By American Academy of Neurology (AAN)

Newswise — MINNEAPOLIS – Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall of a blood vessel in the brain. A new study finds that these aneurysms rarely burst after treatment with clot-busting drugs, so the drugs may be safe for use. The study is published in the October 6, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology.

“These results are exciting because they may expand the population who can receive these thrombolytic therapies that can prevent death and disability for people with strokes,” said study author Jyri Juhani Virta, MD, PhD, of the University of Helsinki in Finland.

- Advertisement -

For the study, researchers looked at the records for all people with a stroke who were treated with clot-busting drugs at a stroke center in Finland over 15 years. After determining how many had unruptured aneurysms, they then looked to see how many people had a hemorrhagic stroke, or an intracranial hemorrhage, caused by the rupture of the aneurysm while they were in the hospital after the treatment.

Of the 3,953 people in the study, 132 people had one or more unruptured aneurysms. Of the 155 unruptured aneurysms, 141 were the type called saccular aneurysms and 14 were fusiform aneurysms.

The aneurysms ruptured after treatment causing a hemorrhagic stroke in only three people, or 2.3%. All three had large aneurysms called fusiform basilar artery aneurysms. All three were treated with blood thinners after their treatment. None of the saccular type of aneurysms ruptured.

“Fortunately, today blood thinners are not commonly used early after ischemic stroke, so that may help to reduce this risk even further,” Virta said. “Our results suggest that thrombolytic therapy may be relatively safe for people with ischemic stroke even if they have larger saccular aneurysms that have not ruptured. For people with large fusiform aneurysms, additional consideration should be taken regarding treatment as blood thinners may increase the risk of aneurysm rupture.”

- Advertisement -

 A limitation of the study was that only a small number of people had large aneurysms.

Learn more about stroke at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, Twitter and Instagram. #Neurology and #AANscience.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Earns Another 5-Star Healthgrades Distinction for Hip Fracture Care

For the sixth consecutive year, STHS McAllen and STHS Edinburg have earned a Five-Star Rating for Hip Fracture Treatment from Healthgrades, one of the nation's leading resources for evaluating hospital performance.

Raising Awareness, One Step at a Time: STHS Edinburg Hosts Sept. 23 Walkathon

To raise awareness about the condition and encourage residents to take proactive steps toward better vascular health, the STHS Limb Salvage & Amputation Prevention Program will host the Step Out PAD Walkathon on Wednesday, September 23, 2026, at STHS Edinburg, from 6:30 to 7:30 p.m.

FDA Launches Expedited IND Pilot to Speed Up Clinical Trials

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot. Accelerating clinical trial timelines and eliminating regulatory hurdles to maintain American leadership in global medical innovation is a core priority for the Trump Administration.

Navigating Cardiovascular Health in Hispanic Communities

Cardiovascular disease is the leading cause of death for Hispanic and Latino people in the United States. But the challenges they face are hardly the whole story, say experts who helped write a new report on the heart health of these communities.
- Advertisement -